| Literature DB >> 35962393 |
Yu-Ching Chen1,2, Yi-Han Liao1, Li-Jung Elizabeth Ku3, Jung-Der Wang1,4.
Abstract
Entities:
Year: 2022 PMID: 35962393 PMCID: PMC9373327 DOI: 10.1186/s12913-022-08368-6
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.908
Adjusted hazard ratios by Cox proportional hazard model for different risk factors of LEA
| Covariate | Adjusted HR (95%CI) | Adjusted HR (95% CI) | Adjusted HR (95% CI) |
|---|---|---|---|
| Model A | Model B | Model C | |
| 0.35 (0.29-0.41)* | 0.37 (0.30-0.44)* | ||
| 0.08 (0.06-0.10)* | |||
| Low COCI (reference) | |||
| Middle COCI | 0.49 (0.43-0.55)* | ||
| High COCI | 0.23 (0.21-0.27)* | ||
| non-P4P, low COCI (reference) | |||
| non-P4P, middle COCI | 0.68 (0.61-0.76)* | ||
| non-P4P, high COCI | 0.26 (0.22-0.31)* | ||
| P4P, low COCI | 0.53 (0.44-0.67)* | ||
| P4P, middle COCI | 0.30 (0.23-0.38)* | ||
| P4P, high COCI | 0.06 (0.04-0.10)* | ||
| Male | 1.16 (1.04-1.29) ǂ | 1.09 (0.99-1.20) | 1.15 (1.02-1.29)+ |
| 56 ≤ yr ≤ 69 | 0.85 (0.73-1.00)+ | 0.81 (0.70-0.94) ǂ | 0.89 (0.75-1.06) |
| yr ≥ 70 | 0.71 (0.60-0.83)* | 0.59 (0.51-0.69)* | 0.73 (0.61-0.87)* |
| 5 ≤ duration <10 | 2.06 (1.54-2.76) | 2.29 (1.76-2.98)* | 2.09 (1.52-2.87)* |
| duration≥ 10 | 3.91 (2.93-5.20) | 4.35 (3.36-5.63)* | 3.90 (2.85-5.32)* |
| 1-2 | 0.55 (0.47-0.64)* | 0.56 (0.48-0.64)* | 0.55 (0.47-0.66)* |
| ≥ 3 | 0.28 (0.21-0.39)* | 0.31 (0.24-0.41)* | 0.30 (0.21-0.41)* |
| 1-2 | 1.07 (0.89-1.29) | 1.05 (0.89-1.24) | 1.11 (0.91-1.35) |
| ≥ 3 | 1.77 (1.28-2.45)* | 1.63 (1.21-2.19) ǂ | 1.89 (1.34-2.65)* |
| Yes | 0.72 (0.56-0.93)+ | 0.82 (0.65-1.05) | 0.77 (0.58-1.01) |
| Urban | 0.82 (0.73-0.92)* | 0.81 (0.73-0.91)* | 0.83 (0.73-0.94) ǂ |
| < NTD 20,000 | 0.96 (0.83-1.10) | 0.96 (0.84-1.09) | 1.00 (0.86-1.15) |
| ≥ NTD 20,000 | 0.85 (0.75-0.97)+ | 0.86 (0.76-0.96) ǂ | 0.91 (0.80-1.04) |
| Regional hospital | 1.14 (1.00-1.31) | 1.11 (0.98-1.26) | 1.13 (0.98-1.31) |
| District hospital | 1.06 (0.92-1.23) | 1.02 (0.89-1.17) | 0.99 (0.83-1.16) |
| Community clinic | 0.87 (0.75-1.01) | 0.86 (0.75-0.99) + | 0.89 (0.75-1.05) |
| 30,787 | 36,804 | 30,699 | |
| 30,888 | 36,918 | 30,794 | |
*p<0.001; ǂ p<0.01; + p<0.05
a Categorical time-dependent time-weighted average COCI, b Stratification of average time weightedaverage COCI by P4P, c Continuous time-weighted average COCI, ref Reference, TWA Time-weighted average, P4P Pay for performance, COCI Continuity of care index, Int Intermediate COCI, CCI Charlson comorbidity index, DSCI Diabetes severity comorbidity index, CDD Catastrophic disabling disease, FP Fixed premium
Page 1, Abstract, Results: With the low COCI (<0.50) group as the reference, the aHR of LEA was 0.49 ( | |
Page 3, Line 2: We divided the COCI scores into 3 subgroups based on the tertiles of the distribution for analysis: low (<0.50), middle (0.50-0.80), and high (≥0.80). | |
Page 8, Left column, Line 9-12: With the low COCI (<0.50) group as the reference, the aHR of LEA was 0.49 ( | |
Page 8, Right column, Line 4-8 In model B, with low COCI (<0.50) subgroup of non-P4P group as the reference, the aHR of LEA was 0.68 ( |